ApoE and Aβ in Alzheimer’s Disease: Accidental Encounters or Partners?

Kanekiyo, Takahisa, Xu, Huaxi, Bu, Guojun·2014·Neuron
DOI 10.1016/j.neuron.2014.01.045

Cited by (626)

Items 601–626 of 626

  1. The neural basis of prosocial effort-based decision making in older adults at risk for Alzheimer’s disease
    Caitlin S. Walker, Garance Barnoin, MItchell Bennett, Colleen S. Hughes, Jennifer Tremblay‐Mercier, R. Nathan Spreng, Judes Poirier, Laurel S. Morris, Sylvia Villeneuve, Maiya Rachel Geddes · 2026 · medRxiv
  2. ApoE and Brain Aging
    R.R. Resende, C. F. Pereira · 2025 · Springer eBooks
  3. Apolipoprotéine E et maladie d’Alzheimer : mécanismes moléculaires et implications thérapeutiques à l’ère du lecanemab
    Maxime Carpentier, Pierre‐Olivier Bertho, Edith Bigot‐Corbel · 2026 · Revue Francophone des Laboratoires
  4. Mechanistic modeling of amyloid dynamics relating to Alzheimer's disease progression
    Andrzej J. Przekwas, Carly Norris, Harsha Teja Garimella · 2026 · Frontiers in Aging Neuroscience
  5. Etude préclinique et clinique de la phase précoce de la maladie d'Alzheimer
    Stéphane Epelbaum · 2015 · theses.fr (ABES)
  6. Molecular mechanisms of action of MT-MMPs involved in the pathogenesis of Alzheimer’s disease
    Laura García‐González · 2020 · theses.fr (ABES)
  7. Rôle de LRP-1 dans la prolifération des cellules issues de cancer du côlon en matrice tridimensionnelle de collagène de type I
    C. Le · 2020 · theses.fr (ABES)
  8. A Comparative Dual-Platform Docking and Dynamic Light Scattering Analysis of Nutraceutical Interactions with the ApoE4–oxLDL Complex
    Giorgia Francesca Saraceno, Daniela Sorrenti, Claudia Ferraro, Erika Cione · 2026 · BioMedInformatics
  9. Proximity labeling reveals unique and shared proximal proteomes associated with pE3-Aβ and 6E10 amyloid pathology in human Alzheimer’s disease hippocampus
    Alia O. Alia, Kristy Urquhart, Hannah Carson, Bryan A. Killinger, Christopher Janson, L. Yu. Romanova · 2026 · Acta Neuropathologica Communications
  10. ApoE and Brain Aging
    R.R. Resende, C. F. Pereira · 2026 · Springer eBooks
  11. Metabolic dysregulation in Alzheimer’s disease: Mechanisms, markers, and therapeutic prospects
    Radhika Mittal, Priya, Jyotirmoy Banerjee, Aparna Dixit · 2026 · International review of neurobiology
  12. APOE4-Expressing Astrocytes Exhibit Parkinson’s Disease–Related Pathology
    Lior Nechushtai, Popov Anna, Haklai Roni, Michaelson M. Daniel, Frenkel Dan, Ronit Pinkas‐Kramarski · 2026 · Molecular Neurobiology
  13. HDL‐mimetic peptide treatment reverses APOE4‐induced transcriptomic and lipidomic alterations in the brain of humanized APOE mice
    Allison Chang, Minwoo Kim, M. Glittenberg, Wenhui Qu, Dan-Ni Li, Ling Li · 2026 · Alzheimer's & Dementia
  14. Apolipoprotein E and infectious diseases: A framework for therapeutic developments
    Viswapriya Viswalingam, Dileep Kumar, Shashank Tewari, Ankit Ganeshpurkar · 2026 · Elsevier eBooks
  15. Apolipoprotein E as a therapeutic target in Alzheimer's disease: A review of basic research and clinical evidence
    Arvinder Kaur, Shilpa Murthy, Bharath Kumar D.R., Gokulakrishnan S., Ugen Palmu Butiya Philantharopa, Chandrashekhar Narajji · 2026 · Elsevier eBooks
  16. Neuroinflammation in Alzheimer’s disease-associated sensory dysfunction: mechanistic links, actionable targets and therapeutic strategies
    Yan Xu, Guimei Zhang, Xinran Cui, Li Sun · 2026 · Frontiers in Aging Neuroscience
  17. Synergetic Effect of Intermittent Fasting and Phytocompounds in Alzheimer’s Disease Management an in Silico analysis
    Kratika Verma, Kaustav M. Chatterjee, Tiasha Raha, Sounak Basak, Trupti Patel · 2026 · Studies in Rhythm Engineering
  18. The single cell origin of sporadic Alzheimer's disease: A developmental biallelic somatic mutation model
    Simon A. Morris · 2026 · Journal of Alzheimer s Disease Reports
  19. Association between Alzheimer’s disease-related genes and neurodegenerative blood-based biomarkers in Indian adults
    Hasan Abu‐Amara, Wei Zhao, Zheng Li, Yuk Yee Leung, Gerard D. Schellenberg, Li‐San Wang, Eileen M. Crimmins, Bharat Thyagarajan, Masroor Anwar, Perry Hu et al. · 2026 · Frontiers in Aging Neuroscience
  20. Dissecting Alzheimer's proteomic landscape through NULISA profiling of brain cell‐specific extracellular vesicles
    Ashish Kumar, Mitu Sharma, Yixin Su, Sangeeta Singh, Jordan E. Tanley, Ramon Casanova, Fang‐Chi Hsu, Suzanne Craft, Michelle M. Mielke, Timothy M. Hughes et al. · 2026 · Alzheimer s & Dementia
  21. Apolipoprotein E lipidation, rather than isoform identity, determines amyloid-β binding and astrocyte clearance
    Kamila Nurmakova, Gregory-Neal W Gomes, Zachary A. Levine · 2026 · Journal of Biological Chemistry
  22. Novel therapies in Alzheimer’s disease
    Denis Pavăl, Octavia Căpățînă, Mihaela Fadgyas Stănculete · 2026 · International review of neurobiology
  23. Clinical and neuropathological aspects of canine cognitive dysfunction syndrome and a translational perspective for Alzheimer's disease
    Evilly Lopes-Gomes, Fernando Francisco Borges Resende, Alexandra Mazer Greuel, Clara Luna Marina, Fabiano José Ferreira de Sant’Ana, Simoneide Souza Titze-de-Almeida, Ricardo Titze‐de‐Almeida · 2026 · Journal of Alzheimer s Disease
  24. Disease-specific glycosylation in the neurodegenerative brain
    Meredith Edwards, Natasha Vassileff, Joern R Steinert, Jereme G. Spiers · 2026 · Elsevier eBooks
  25. Immunopharmacology of proton pump inhibitors in Alzheimer's Disease: An evidence-weighted mechanistic review of Neuroinflammation, neuroprotection, and neurodegeneration
    Faisal Alshammari, Hayder M. Al‐kuraishy, Ahmed M Abdelaziz, Mubarak Alruwaili, Gaber El‐Saber Batiha · 2026 · International Immunopharmacology
  26. Cd47 deficiency in mouse brain under excitotoxic stress
    Mehrdad Kiamari, Amalia Perna, Matteo Santoro, Abdel El Ariss, Eloïse Berson, Jing Zhao, Chandresh R. Gajera, Edward J. Fox, Kathleen S. Montine, Nima Aghaeepour et al. · 2026 · PLoS Computational Biology